Premium
HeartBeam Inc (BEAT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with care management of patients with cardio... HeartBeam Inc is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Its initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Show more
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia assessment The Company is gearing up for an Early Access Program to gain initial...
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the...
The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG The first...
Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, will hold a conference call on...
Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions HeartBeam, Inc. (NASDAQ:...
Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth Founder and current CEO Branislav Vajdic named President to...
Industry Leader, Former Head of Data Science at Verily (Google Life Sciences) and Globally Respected Authority on Artificial Intelligence (AI) Applications in Biosensor Technologies Dr. Myers to...
Seasoned MedTech Leader with Proven Track Record of Strategic Planning, Financial Stewardship and Commercial Success HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on...
Continued Clinical and Regulatory Progress on the HeartBeam AIMIGo™ System Enrollment Complete in VALID-ECG Clinical Study That Will Be the Basis of the Upcoming FDA Submission on the 12-Lead...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.2 | -8.65800865801 | 2.31 | 2.4 | 2.02 | 133991 | 2.2367413 | CS |
| 4 | -0.9832 | -31.7858528385 | 3.0932 | 3.27 | 2.02 | 308606 | 2.58567937 | CS |
| 12 | -0.1 | -4.52488687783 | 2.21 | 3.35 | 2.02 | 170268 | 2.62055464 | CS |
| 26 | -0.89 | -29.6666666667 | 3 | 3.35 | 2 | 109204 | 2.54071578 | CS |
| 52 | 0.12 | 6.03015075377 | 1.99 | 3.3893 | 1.35 | 116578 | 2.38191379 | CS |
| 156 | -1.38 | -39.5415472779 | 3.49 | 6.74 | 1.06 | 481319 | 2.86035233 | CS |
| 260 | -48.11 | -95.7984866587 | 50.22 | 73.1 | 1.06 | 398296 | 15.62915664 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
